Gabrail Cancer and Research Center

Gabrail Cancer and Research Center Gabrail Cancer Center is a privately-owned, community-based facility. Each year, he treats over 200 different subtypes of cancer.

We are dedicated to provide a full range of services to meet the unique medical needs of our patients, including the latest Oncology and Hematology clinical trials. Founded by Dr. Nashat Gabrail in 1990, the Gabrail Cancer Center was opened in Stark County in Ohio. Due to the increasing amount of patients traveling long distances for treatment, a satellite office was opened in Tuscarawas County in 1999. Gabrail Cancer Center then relocated to Canton, Ohio in 2005 to accommodate the expansion of the practice to include Clinical Trials and Instant Imaging, an in-house dedicated medical imaging center. Gabrail Cancer Center is constantly renovating and expanding to meet the growing needs of patients and the community! Gabrail Cancer Center experts have established standards of care and treatment protocols for each type and stage of cancer. Dr. Gabrail has an extraordinary depth and breadth of experience in diagnosing and treating all forms of cancer, from the most common to the very rare diagnoses. This level of specialization can have an often dramatic effect on patients chances for a cure or control of their healthcare plane. While Gabrail Cancer Center is known for our advanced, innovative therapies, Dr. Gabrail is well-regarded for his compassion and concern for his patients. Gabrail Cancer Center has adopted a patient-focused philosophy to provide a variety of services that span the full range of practical and emotional needs

Financial counselors are readily available to assist patients in meeting the needs of the expenses of treatment and applying for pharmaceutical assistance programs.

08/25/2025

Sargon Research is helping oncology practices to overcome the challenges to participating in meaningful research. Sargon is your gateway to a viable and economically-sound clinical research program.

08/07/2025

SARGON ICOP Summit 2025! 📅 September 12–13 | 📍 Canton, Ohio

Kick off the weekend early:
⛳️ Thursday, September 11 – Enjoy a round of golf, relax, and connect with fellow attendees. For details and registration, reach out directly to Carrie Smith.

This can’t-miss event brings together leaders in community oncology research to collaborate, share insights, and help drive the future of cancer care.

⚠️ Space is limited – priority will be given to ICOP and Sargon-affiliated practices.

🎟️ Registration fees:
• $800 for non-members
• $500 each for groups of 3+ from the same company
• Free for Sargon members

👉 Reserve your spot now: www.sargonresearch.com

08/06/2025

Find out what Sargon Research can do for you! Join us this in September and experience it firsthand.

Registration is now open for the 2025 SARGON ICOP Summit, happening September 12–13 in Canton, Ohio.

This premier event brings together top healthcare leaders, innovators, and professionals from across the ICOP network. Whether you're a returning member or exploring for the first time, it’s an ideal opportunity to connect, collaborate, and grow your impact.

Planning to arrive early? Don’t miss the optional Golf Day on Thursday, September 11 — a great chance to unwind and network ahead of the summit. To register for Golf Day, please contact Carrie Smith directly.

Registration Fees:
• $800 for non-members
• $500 each for groups of 3 or more from the same organization
• Complimentary for members

Please note: Space is limited and priority will be given to ICOP and Sargon-affiliated practices.

Secure your spot today at www.sargonresearch.com

07/17/2025
Gabrail Cancer and Research Center is currently enrolling patients with breast cancer in a new clinical trial. Please ta...
07/17/2024

Gabrail Cancer and Research Center is currently enrolling patients with breast cancer in a new clinical trial. Please take a look at the attached poster to learn more about the INAVO121 study!

If you or someone you know is interested and would like additional information, please call (330)-492-3345 or email recruitment@gabrailcancercenter.com

Gabrail Cancer and Research Center is currently enrolling patients with small cell lung cancer for the ASTRIDE HLX10-005...
07/09/2024

Gabrail Cancer and Research Center is currently enrolling patients with small cell lung cancer for the ASTRIDE HLX10-005-SCLC301 clinical trial. The ASTRIDE study is testing an investigational drug to see if it can help adults with extensive stage (ES) SCLC. Researchers want to compare the effects of the study drug + chemotherapy with the effects of an already approved drug (atezolizumab) + chemotherapy.

If you or anyone you know has ES-SCLC and is interested in learning more about the study, please call (330) 492-3345 or email recruitment@gabrailcancercenter.com.

Gabrail Cancer and Research Center is enrolling patients with breast cancer for the Genentech evERA Breast Cancer Study ...
07/02/2024

Gabrail Cancer and Research Center is enrolling patients with breast cancer for the Genentech evERA Breast Cancer Study clinical trial.

If you or someone you know is interested in learning more, please call (330) 492-3345 or email recruitment@gabrailcancercenter.com

Gabrail Cancer and Research Center is enrolling patients with Unresectable Advanced, Metastatic, or Recurrent Biliary Tr...
06/24/2024

Gabrail Cancer and Research Center is enrolling patients with Unresectable Advanced, Metastatic, or Recurrent Biliary Tract Cancers for the Compass Therapeutics CTX-009-002 clinical trial.

If you or someone you know is interested in learning more, please call (330) 492-3345 or email recruitment@gabrailcancercenter.com

Gabrail Cancer & Research Center is currently enrolling eligible females who have high triglycerides in a blood collecti...
06/18/2024

Gabrail Cancer & Research Center is currently enrolling eligible females who have high triglycerides in a blood collection study. All participants will be compensated $50 for their involvement in the study.

If you or someone you know is interested in learning more, please call 330-492-3345 x 207 or email recruitment@gabrailcancercenter.com

Gabrail Cancer & Research Center is enrolling patients with Higher-Risk Myelodysplastic Syndrome (MDS) for the AK117-205...
06/18/2024

Gabrail Cancer & Research Center is enrolling patients with Higher-Risk Myelodysplastic Syndrome (MDS) for the AK117-205 clinical trial.

If you or someone you know is interested in learning more, please call (330) 492-3345 or email recruitment@gabrailcancercenter.com

Address

4875 Higbee Avenue NW
Canton, OH
44718

Opening Hours

Monday 8am - 4:30pm
Tuesday 8am - 4:30pm
Wednesday 8am - 4:30pm
Thursday 8am - 4:30pm
Friday 8am - 4:30pm

Telephone

+13304923345

Website

http://linkedin.com/company/gabrailcancerandresearchcenter

Alerts

Be the first to know and let us send you an email when Gabrail Cancer and Research Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Gabrail Cancer and Research Center:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category